Rising Hearing Loss in Africa by 2030: Urgent Measures Needed

By Crystal Lubbe

October 17, 2024

The article from the World Health Organization (WHO) Regional Office for Africa, titled “Burden of hearing loss in Africa could rise to 54 million by 2030: WHO report,” presents a comprehensive analysis of the “burden of hearing loss in Africa” and its future projections.

Current Hearing loss Prevalence and Projections for 2030

Currently, 40 million people in Africa manage hearing loss, and this number will likely grow to 54 million by 2030. Without action, the burden of hearing loss in Africa will rise to 97 million by 2050.

Economic and Social Impact of hearing loss in Africa

The economic and social impact of hearing loss is significant, costing the continent around $27 billion annually. This issue profoundly affects human lives, delaying language development in children, leading to poor educational outcomes, and limiting career prospects. Furthermore, adults face increased risks of isolation, loneliness, depression, and dementia.

Factors Driving the Surge in Hearing Loss

Hearing loss in Africa is exacerbated by several factors, including a severe shortage of ear and hearing care (EHC) specialists, with over 56% of African countries having only one ear, nose, and throat (ENT) specialist per million people, compared to approximately 50 per million in Europe. This workforce is also unevenly distributed, concentrated mainly in urban areas, leaving rural populations underserved. Furthermore, only about 10% of the 33 million Africans in need of hearing aids have access, largely due to high costs and financial barriers.

Preventable Causes

A significant portion of hearing loss is preventable. Up to 75% of hearing loss in children from low- and middle-income countries results from preventable causes such as infections, common ear diseases, and birth complications. Nonetheless, many countries fail to conduct routine hearing screenings for newborns.

Integration and Policy Gaps

EHC services are often not included in priority health programs like school health, occupational health, or healthy aging initiatives. Many nations lack national policies to strengthen EHC delivery, and those with plans often see low implementation levels. Alarmingly, 35% of countries do not provide a budget for EHC activities, shifting the financial burden onto patients.

Recommendations

The report urges several critical actions:

  • Nations must advocate for policies focused on EHC and related activities.
  • Countries should integrate EHC into existing health programs to maximize resource use.
  • Authorities need to pursue public-private partnerships to strengthen EHC services.
  • Governments must allocate dedicated funding to equip facilities, provide essential products and technologies, and boost health workforce capacity and EHC research.

Overall, the report emphasizes the urgent necessity for comprehensive and integrated strategies to tackle the growing burden of hearing loss in Africa effectively.

Reference url

Recent Posts

Novartis patent cliff layoffs
     

Engineering Resilience: Mastering Pharma Patent Expiration Strategy

🚨 Are you still reacting to pharmaceutical patent expirations with layoffs and litigation, or are you ready to engineer a strategy that turns the patent cliff into your next competitive edge?

Patent expirations don’t have to derail your pharma portfolio. Learn how to outmaneuver generics and transform challenges into advantages. Dive into our latest insights and take control today.

#SyenzaNews #pharmaceuticals #innovation #PharmaStrategy #patentcliffs

diabetes medicine access
               

Improving Diabetes Medicine Access: Key Changes in the Pharmaceutical Benefits Scheme

🚀 Are we on the verge of a breakthrough in diabetes medication accessibility?

The latest updates to the Pharmaceutical Benefits Scheme (PBS) are set to transform type 2 diabetes management by expanding access to essential medicines like empagliflozin and streamlining the prescribing process for glucagon-like peptide 1 receptor agonists (GLP-1 RAs). These changes not only prioritize equity for high-risk populations but also align with global trends in cost-effective healthcare.

Dive deeper into how these revisions could reshape diabetes care and promote better health outcomes for all.

#SyenzaNews #HealthcareInnovation #healthcare #MarketAccess

HPV testing HNSCC
    

HPV Testing in Head and Neck Squamous Cell Carcinoma

🔍 Are you up-to-date with the latest advancements in HPV testing for head and neck cancer?

Our comprehensive article looks into the innovation of diagnostic methods for HPV status determination in head and neck squamous cell carcinoma (HNSCC). From traditional p16 immunohistochemistry to innovative liquid biopsies, discover the critical role these advancements play in prognosis, treatment planning, and improving patient outcomes.

Look into this essential topic and see how these insights could revolutionize clinical practices.

#SyenzaNews #oncology #HealthTech #HealthcareInnovation

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.